ClinicalTrials.gov
public full text
Public Domain
A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006)
This is a randomised, double-blind, placebo-controlled, crossover, single centre study of gefapixant (AF-219/MK-7264) in participants with idiopathic or treatment resistant chronic cough designed to evaluate the effectiveness of gefapixant in reducing daytime objective cough frequency.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension#1073588
- A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)#906130
- Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough#877130
- Impact of Refractory Chronic Cough on Activities of Daily Living and Response to Acute High-intensity Exercise#1138059
- Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF#800651
Record · ID 1103763
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive